BABA News Alert Alibaba Group Holding Ltd. (BABA) 103.60 01/03/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Alibaba Group Holding Ltd. (BABA) 103.60 $BABA

Baidu Smartwatch App: Dead On Arrival
WestEnd511 - at Seeking Alpha - Sat Jan 03, 9:29AM CST

BIDU: 223.08 (-4.89), GOOGL: 529.55 (-1.11), GOOG: 524.81 (-1.59), BABA: 103.60 (-0.34)

'Fast Money' Recap: Where's the Market Going This Year?
at The Street - Sat Jan 03, 4:00AM CST
The trading panel discussed the 'January effect,' which loser stocks will win this year and whether Apple is a defensive play.
YHOO: 50.17 (-0.34), DDD: 32.42 (-0.45), FCX: 23.55 (+0.19), JCP: 6.29 (-0.19), TIF: 105.50 (-1.36), IWM: 118.93 (-0.69), TWTR: 36.56 (+0.69), SNI: 75.94 (+0.67), AAPL: 109.33 (-1.05), BABA: 103.60 (-0.34)

Apple 2015 Outlook: Where Do We Go From Here?
WestEnd511 - at Seeking Alpha - Fri Jan 02, 10:07PM CST

QIHU: 59.71 (+2.45), QUNR: 28.47 (+0.04), BIDU: 223.08 (-4.89), AAPL: 109.33 (-1.05), BABA: 103.60 (-0.34)

Stock classes on center stage
at Investor's Business Daily - Fri Jan 02, 5:42PM CST
Chinese online retail giant Alibaba's (BABA) Sept. IPO put dual-class stocks -- which give some holders, usually company founders and key executives, shares with more voting rights than others -- in the news. Google (GOOGL), which already had a...
GOOGL: 529.55 (-1.11), BABA: 103.60 (-0.34)

Alipay parent launches credit service for Alibaba purchases
Seeking Alpha - at Seeking Alpha - Fri Jan 02, 4:07PM CST

BABA: 103.60 (-0.34)

Alibaba E-Commerce Unit Now Offering Shoppers Loans
at Investor's Business Daily - Fri Jan 02, 3:03PM CST
Alibaba Holdings' (BABA) e-commerce affiliate Ant Financial Services Group reportedly announced this week that shoppers on Alibaba's Tmall and Taobao e-commerce sites can now take out month-to-month loans of up to $4,800 using a new payment option...
SINA: 37.81 (+0.40), M: 65.69 (-0.06), JD: 24.02 (+0.88), BABA: 103.60 (-0.34)

Kabam's IPO Plans Are Kaput
Larry Abrams - Seeking Alpha - Fri Jan 02, 2:44PM CST
We are just a couple days into the New Year and already we have our first scratch - Kabam - from lists of technology companies most likely to do a 2015 IPO. Kabam is a San Francisco-based mobile gaming company that had a track record of licensing...
ZNGA: 2.73 (+0.07), KING: 15.06 (-0.30), BABA: 103.60 (-0.34)

Alibaba, Facebook Led Dual-Class 2014 Tech Stocks
at Investor's Business Daily - Fri Jan 02, 8:41AM CST
Alibaba Group Holding's (BABA) September IPO put dual-class stocks back in the spotlight, while Google, which already had a dual-class stock, in April created a new class of nonvoting stock with its stock split, creating a tri-class stock. Dual-class...
TSLA: 219.31 (-3.10), AMZN: 308.52 (-1.83), LNKD: 229.65 (-0.06), FB: 78.45 (+0.43), ZNGA: 2.73 (+0.07), YELP: 55.15 (+0.42), GRPN: 8.02 (-0.24), AAPL: 109.33 (-1.05), DISH: 72.27 (-0.62), BABA: 103.60 (-0.34)

10 Big Mergers, Acquisitions and Spinoffs to Be on the Lookout for in 2015
at The Street - Thu Jan 01, 8:00AM CST
Next year looks to be another busy one for M&A and spinoffs, from tie-ups that could re-shape the cable industry to big breakups in Silicon Valley.
YHOO: 50.17 (-0.34), GS: 194.41 (+0.58), DLTR: 70.35 (-0.03), EBAY: 56.21 (+0.09), AOL: 45.49 (-0.68), HAL: 39.49 (+0.16), DG: 70.78 (+0.08), FDO: 78.89 (-0.32), HPQ: 40.24 (+0.11), BHI: 56.17 (+0.10), BABA: 103.60 (-0.34)

BitAuto, Avago Among 2014's Top World Stocks Winners
at Investor's Business Daily - Wed Dec 31, 5:44PM CST
A fascinating year for global markets and economies has driven IBD's evolving list of Top World Stocks. As always, some stocks mentioned on the list and in the International Leaders columns proved out and booked significant gains. Others sputtered....
RDWR: 21.77 (-0.25), NTES: 98.81 (-0.33), JAZZ: 163.43 (-0.30), AVGO: 100.09 (-0.50), BITA: 74.71 (+4.30), BABA: 103.60 (-0.34), TTM: 43.84 (+1.56)

Top 5 Internet Stocks Include Facebook, Baidu
at Investor's Business Daily - Wed Dec 31, 3:53PM CST
As we head into a new year, a look at the top five Internet stocks shows four of the biggest names in the sector, along with a fast-growing Chinese company. IBD's 68-company Internet-Content industry group ended the year almost exactly where it...
YHOO: 50.17 (-0.34), BIDU: 223.08 (-4.89), LNKD: 229.65 (-0.06), FB: 78.45 (+0.43), AOL: 45.49 (-0.68), GOOGL: 529.55 (-1.11), BITA: 74.71 (+4.30), BABA: 103.60 (-0.34)


Top business stories of 2014: US grows, world slows
By TALI ARBEL - AP - Wed Dec 31, 3:09PM CST
NEW YORK (AP) — This year showed how sheltered the U.S. economy is from geopolitical and health crises around the world. The global economy sputtered, but the U.S. powered ahead. Employers are finally hiring enough to lower unemployment. A plunge in gas prices and a rising stock market has Americans feeling richer and spending a bit more.
HD: 103.43 (-1.54), TGT: 75.33 (-0.58), WMT: 85.90 (+0.02), GM: 34.84 (-0.07), AAPL: 109.33 (-1.05), BABA: 103.60 (-0.34)

Google's Gmail Service Creeps Back to Life in China - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 31, 2:55PM CST
Reportedly, Google Inc.'s (GOOGL) Gmail has started witnessing some amount of traffic in China after the nation's censorship mechanism, often referred to as the Great Firewall, pulled the plug on the service.
GOOGL: 529.55 (-1.11), MSFT: 46.76 (+0.31), AAPL: 109.33 (-1.05), BABA: 103.60 (-0.34)

China IPOs: A Banner Year Where Firsts Win Big
Doug Young - at Seeking Alpha - Wed Dec 31, 1:26PM CST
Bottom line: New IPOs by Chinese tech firms will slow sharply next year, with profitable, sector-leading companies the most likely to make successful offerings. On this final day of 2014, I thought I'd take a look at the scorecard for high-tech...
WUBA: 41.90 (+0.35), WB: 14.53 (+0.29), GOMO: 5.01 (+0.02), JMEI: 13.88 (+0.26), XNET: 8.00 (+0.70), ATHM: 37.79 (+1.43), BABA: 103.60 (-0.34)

Yahoo 2015 Outlook: Mobile Monetization And Tax Efficiency In Focus
WestEnd511 - at Seeking Alpha - Wed Dec 31, 12:59PM CST

YHOO: 50.17 (-0.34), BABA: 103.60 (-0.34)

Alibaba Tries Domestic Credit, Global Platform
Doug Young - Seeking Alpha - Wed Dec 31, 9:35AM CST
Bottom line: Alibaba's (NYSE: BABA ) new online credit product and global shopping mall look like smart new initiatives that could help maintain its strong growth to justify its high valuation. It has been quite a while since I've written about...
BABA: 103.60 (-0.34)

Worst Performing IPOs of 2014 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 31, 8:10AM CST
The average offering return was at 16% in 2014, significantly lower than 41% in 2013
E: 34.98 (+0.07), SC: 20.00 (+0.39), ALLY: 23.65 (+0.03), FB: 78.45 (+0.43), BIOC: 2.48 (unch), NADL: 1.68 (+0.05), RBS: 11.93 (-0.18), ATEN: 4.54 (+0.18), V: 265.02 (+2.82), CFG: 24.76 (-0.10), SYF: 29.48 (-0.27), PGRE: 18.78 (+0.19), NDAQ: 47.86 (-0.10), AM: 27.41 (-0.09), REPH: 2.90 (+0.04), BABA: 103.60 (-0.34)

SoftBank Will Get 2% Share Of My 2015 Portfolio
Alcaraz Research - at Seeking Alpha - Wed Dec 31, 7:59AM CST

YHOO: 50.17 (-0.34), S: 4.24 (+0.09), BABA: 103.60 (-0.34)

Media: Streaming, mergers, and theater traffic big themes of 2015
Seeking Alpha - at Seeking Alpha - Wed Dec 31, 7:42AM CST

SNE: 20.56 (+0.09), SNI: 75.94 (+0.67), RGC: 20.84 (-0.52), CNK: 34.91 (-0.67), TWX: 84.93 (-0.49), MSG: 75.26 (unch), VIA: 75.46 (-0.04), LGF: 31.22 (-0.80), FOXA: 37.85 (-0.55), DTV: 86.67 (-0.03), TWC: 150.66 (-1.40), STRZA: 29.44 (-0.26), AMCX: 63.90 (+0.13), DIS: 93.75 (-0.44), DWA: 22.65 (+0.32), DISH: 72.27 (-0.62), IMAX: 30.03 (-0.87), NFLX: 348.94 (+7.33), AMC: 25.63 (-0.55), CKEC: 25.82 (-0.45), VIAB: 75.40 (+0.15), CMCSA: 57.35 (-0.66), CBS: 54.79 (-0.55), BABA: 103.60 (-0.34)

Vipshop: 3 Things That Matter Most In 2015
Brian Nichols - at Seeking Alpha - Tue Dec 30, 1:51PM CST

VIPS: 20.50 (+0.96), JD: 24.02 (+0.88), BABA: 103.60 (-0.34)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 8

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

HeartCore's Journey: From Nasdaq Challenges to Growth Potential

Updated Category News Views 35

HeartCore's Nasdaq Delisting Challenge HeartCore Enterprises, Inc. (NASDAQ:HTCR), a provider of enterprise software and consulting services, is currently facing a significant challenge related to its listing on the Nasdaq Capital Market. The company has received notice of non-compliance with the minimum bid price requirement, which mandates that its stock price must be at...

Continue Reading
Mitchell Capital Expands Portfolio with Optelos Acquisition

Updated Category News Views 236

Mitchell Capital's New Acquisition of Optelos Mitchell Capital, a prominent private equity firm, recently announced a significant acquisition that marks a pivotal moment for their long-term investment strategy. They have secured a controlling interest in Optelos, a distinguished provider of digital twin platforms that are tailored for enhancing critical infrastructure...

Continue Reading
Tampa Bay Lightning and Scripps Sports Forge Exciting Partnership

Updated Category News Views 247

Partnership Announcement Between Tampa Bay Lightning and Scripps Sports The Tampa Bay Lightning have officially entered into an exciting multi-year partnership with Scripps Sports. This collaboration signifies a new chapter for the Tampa Bay Lightning, expanding their reach in broadcasting and enhancing viewer engagement with National Hockey League (NHL) games. Through...

Continue Reading
Kazia Therapeutics Sets Meeting with FDA on Glioblastoma Treatment

Updated Category News Views 61

Kazia Therapeutics Prepares for FDA Meeting on Paxalisib Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is set to meet with the U.S. Food and Drug Administration (FDA) to explore potential pathways for the registration of its innovative drug, Paxalisib, aimed at treating newly diagnosed glioblastoma multiforme (GBM). This crucial...

Continue Reading
Important Notice for Flux Power Investors on Lead Plaintiff Claims

Updated Category News Views 100

Overview of Flux Power Investor Claims Investors with concerns regarding their investments in Flux Power Holdings, Inc. (NASDAQ: FLUX) have much to consider as recent developments unfold. The national securities law firm, Faruqi & Faruqi, LLP, is actively investigating claims that could impact investor interests and is eager to assist those affected. Critical Investment...

Continue Reading